News Archive

2019

November

Media Release / Nov 08, 2019

Novartis receives FDA approval for BEOVU®, offering wet AMD patients vision gains and greater fluid reductions vs aflibercept

Read More

October

Media Release / Oct 08, 2019

Novartis STEP Program™ now accepting submissions for proposals that address unmet patient needs in cancer biomarker testing

Read More
Media Release / Oct 02, 2019

Novartis positive 52-week PREVENT data confirm Cosentyx® efficacy in addressing entire axSpA spectrum

Read More
Media Release / Oct 01, 2019

Novartis Entresto receives FDA approval for pediatric heart failure, helping to address critical unmet need for treatment options

Read More

September

Novartis scientist talks to woman on the street.
Story / Sep 30, 2019

Word on the Street: What is cell and gene therapy?

We leave the lab to find out what people know about cell and gene therapy.

Read More
Featured News / Sep 24, 2019

Form 483 posting by US Food and Drug Administration (FDA) – Novartis statement

Read More
Media Release / Sep 19, 2019

AveXis presents new data at EPNS continuing to show significant therapeutic benefit of Zolgensma® in prolonging event-free survival now up to 5 years of age in patients with spinal muscular atrophy (SMA) Type 1

Read More
Media Release / Sep 16, 2019

Initiation of Novartis Entresto in-hospital included in the new ACC Expert Consensus Decision Pathway developed to improve management of hospitalized heart failure patients

Read More
Media Release / Sep 02, 2019

Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findings

Read More

July

Media Release / Jul 22, 2019

Novartis Teams Up With Celebrity Interior Designer Nate Berkus To Launch My Home In Sight, A Program Empowering People With Wet AMD To Live More Independently At Home

Read More

Related Links